易明医药: 股票交易异常波动公告暨风险提示公告

Group 1 - The company, Tibet Yiming Xiya Pharmaceutical Technology Co., Ltd., announced a significant change in control due to a share transfer agreement signed between the controlling shareholder Gao Fan and Beijing Fuhai, involving the transfer of 43,855,883 shares, which represents a substantial portion of the company's total shares [3][4]. - The company's stock experienced abnormal trading fluctuations, with a cumulative price deviation exceeding 20% over three consecutive trading days from July 23 to July 25, 2025 [2]. - The board of directors confirmed that there are no undisclosed significant matters or ongoing negotiations that would require disclosure under the Shenzhen Stock Exchange regulations, ensuring transparency in the company's operations [4][5]. Group 2 - The company is currently in the process of preparing its semi-annual report, and as of now, it has not reached the threshold that would necessitate a performance forecast disclosure according to the Shenzhen Stock Exchange rules [5]. - The company will continue to adhere strictly to legal and regulatory requirements regarding information disclosure and will ensure timely updates to stakeholders [4].